Guyasuta Investment Advisors’s GSK GSK Stock Holding History

Guyasuta Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$245K	Buy	4,669 +3	+0.1%	+$159	0.01%	254
2026 Q1	$258K	Buy	4,666 +3	+0.1%	+$163	0.01%	244
2025 Q4	$229K	Buy	4,663 +3	+0.1%	+$140	0.01%	246
2025 Q3	$201K	Buy	+4,660	New	+$182K	0.01%	261
2022 Q3	–	Sell	-4,078	Closed	-$222K	–	235
2022 Q2	$222K	Hold	4,078	–	–	0.02%	245
2022 Q1	$222K	Sell	4,078 -320	-7%	-$17.4K	0.02%	261
2021 Q4	$242K	Hold	4,398	–	–	0.02%	252
2021 Q3	$210K	Buy	4,398 +80	+2%	+$4.02K	0.02%	258
2021 Q2	$215K	Sell	4,318 -400	-8%	-$19.2K	0.02%	252
2021 Q1	$210K	Sell	4,718 -224	-5%	-$10.2K	0.02%	237
2020 Q4	$227K	Hold	4,942	–	–	0.02%	216
2020 Q3	$233K	Hold	4,942	–	–	0.02%	197
2020 Q2	$252K	Buy	4,942 +400	+9%	+$20.5K	0.03%	188
2020 Q1	$215K	Buy	4,542 +400	+10%	+$21.3K	0.03%	176
2019 Q4	$243K	Hold	4,142	–	–	0.02%	190
2019 Q3	$221K	Sell	4,142 -280	-6%	-$14.4K	0.02%	193
2019 Q2	$221K	Hold	4,422	–	–	0.02%	200
2019 Q1	$231K	Sell	4,422 -260	-6%	-$13K	0.03%	193
2018 Q4	$224K	Buy	4,682 +400	+9%	+$19.7K	0.03%	188
2018 Q3	$215K	Sell	4,282 -112	-3%	-$5.69K	0.02%	208
2018 Q2	$221K	Hold	4,394	–	–	0.03%	200
2018 Q1	$215K	Buy	+4,394	New	+$205K	0.03%	206
2017 Q4	–	Sell	-6,554	Closed	-$333K	–	223
2017 Q3	$333K	Hold	6,554	–	–	0.04%	173
2017 Q2	$353K	Hold	6,554	–	–	0.04%	160
2017 Q1	$345K	Hold	6,554	–	–	0.04%	165
2016 Q4	$315K	Hold	6,554	–	–	0.04%	165
2016 Q3	$353K	Hold	6,554	–	–	0.05%	157
2016 Q2	$355K	Hold	6,554	–	–	0.05%	156
2016 Q1	$332K	Sell	6,554 -4,000	-38%	-$199K	0.05%	160
2015 Q4	$532K	Buy	10,554 +120	+1%	+$6.12K	0.07%	132
2015 Q3	$501K	Buy	10,434 +336	+3%	+$17.5K	0.07%	142
2015 Q2	$525K	Buy	10,098 +5,200	+106%	+$293K	0.07%	150
2015 Q1	$282K	Buy	4,898 +1,000	+26%	+$57.3K	0.04%	179
2014 Q4	$208K	Sell	3,898 -300	-7%	-$16.8K	0.03%	199
2014 Q3	$241K	Hold	4,198	–	–	0.03%	187
2014 Q2	$280K	Hold	4,198	–	–	0.04%	172
2014 Q1	$280K	Hold	4,198	–	–	0.04%	166
2013 Q4	$280K	Buy	4,198 +300	+8%	+$19.5K	0.04%	164
2013 Q3	$244K	Hold	3,898	–	–	0.04%	170
2013 Q2	$243K	Buy	+3,898	New	+$247K	0.04%	162

Other funds holding GSK

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EIC

Equity Investment Corp Atlanta, Georgia $5.24B AUM 11.32% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

MHI

Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Guyasuta Investment Advisors's GSK Position: Q2 2026 in Review

Guyasuta Investment Advisors increased its GSK (GSK) stake by 0.06% in Q2 2026, buying an estimated $159 and bringing the position to 4,669 shares worth $245K. The position accounts for 0.01% of the portfolio, ranked #254.

Guyasuta Investment Advisors first reported a position in GSK in Q2 2013 and has held it in 40 quarters since. The position peaked at $532K in Q4 2015. 627 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Guyasuta Investment Advisors held 4,669 shares of GSK worth $245K as of Q2 2026.
Guyasuta Investment Advisors bought 3 GSK shares in Q2 2026, an estimated $159.
GSK made up 0.01% of Guyasuta Investment Advisors's portfolio in Q2 2026, its #254 holding.
Guyasuta Investment Advisors first reported a position in GSK in Q2 2013 and has held it in 40 quarters since.
Guyasuta Investment Advisors's GSK position peaked at $532K in Q4 2015.
627 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Guyasuta Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.